FGL1 and neoplasm: Additionally, the therapeutic effect of anti-FGL1 mAb i.p. once every 3 days 5 times was demonstrated by the significantly prolonged survival of mice with liver metastasis of B16-F10 tumor cells (Figure 6, H and I).